These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8374294)

  • 1. [Antibody induction after intrauterine interventions].
    Hoch J; Giers G; Bald R; Hansmann M; Hanfland P
    Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():70-3. PubMed ID: 8374294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Specificity and incidence of erythrocyte antibodies in pregnant patients with intrauterine transfusions for fetal erythroblastosis].
    Hoch H; Giers G; Bald R; Hanfland P
    Beitr Infusionsther; 1992; 30():439-42. PubMed ID: 1284755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prenatal diagnosis and therapy of hemolytic disease of the newborn].
    Fischer K; Poschmann A; Hellwege HH; Kitschke HJ; Carstensen M; Sprotte C; Schreer I
    Monatsschr Kinderheilkd; 1985 Mar; 133(3):167-70. PubMed ID: 4010672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yta isoimmunization in pregnancy. A case report.
    Sacks DA; Johnson CS
    J Reprod Med; 1983 Jun; 28(6):407-9. PubMed ID: 6887148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prenatal diagnosis and prevention of hemolytic disease of newborn].
    Fischer K
    Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():64-9. PubMed ID: 8374293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fetal hemolytic disease in a patient immunized by six antibodies: diagnosis and treatment].
    Tantalo V; Rossi E; Gianotti GA; Morotti R; Zuliani G; Buscaglia M; Galligani M
    Ann Ostet Ginecol Med Perinat; 1990; 111(5):321-5. PubMed ID: 2092607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Irregular blood group antibodies during pregnancy: screening is mandatory].
    Semmekrot BA; de Man AJ; Boekkooi PF; van Dijk BA
    Ned Tijdschr Geneeskd; 1999 Jul; 143(28):1449-52. PubMed ID: 10443258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fetomaternal macrotransfusion--a cause for decreased fetal movements. 2 cases].
    Salfelder A; Kochanowicz J; Spenner R; Hickl EJ
    Z Geburtshilfe Neonatol; 1995; 199(2):86-9. PubMed ID: 7540501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of isoimmunization in the presence of multiple maternal antibodies.
    Spong CY; Porter AE; Queenan JT
    Am J Obstet Gynecol; 2001 Aug; 185(2):481-4. PubMed ID: 11518913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of intrauterine transfusions on morphological picture of red cells in Rh incompatibility.
    Lozińska D
    Arch Immunol Ther Exp (Warsz); 1987; 35(6):775-9. PubMed ID: 2468318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiotocographic changes after umbilical cord puncture and umbilical cord transfusion].
    Gremm B; Sohn C; Tochtermann S; Bastert G
    Zentralbl Gynakol; 1997; 119(4):173-6. PubMed ID: 9206923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rh disease: intrauterine intravascular fetal blood transfusion by cordocentesis.
    Onderoğlu L; Oncüloğlu C
    Turk J Pediatr; 1999; 41(1):61-5. PubMed ID: 10770677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the enzyme test for the detection of clinically significant red blood cell antibodies during pregnancy.
    Hundrić-Haspl Z; Juraković-Loncar N; Grgicević D
    Acta Med Croatica; 1999; 53(3):125-8. PubMed ID: 10705633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical aspects of Rh incompatibility. II. Discrepancy between high anti-D titer and incipient mild hemolytic disease of the newborn].
    Gmyrek D; Reitzig C; Schubert S; Syllm-Rapoport I
    Dtsch Gesundheitsw; 1971 Apr; 26(15):687-92. PubMed ID: 5103567
    [No Abstract]   [Full Text] [Related]  

  • 15. [Haemolytic disease of the newborn--from a mother with anti-Kell, anti-E and anti-Vel anti-erythrocyte alloantibodies].
    Vućinović M; Jadrić H; Karelović D; Roje D; Haspl-Hundrić Z; Hrgović Z; Vućinović Z
    Z Geburtshilfe Neonatol; 2004 Oct; 208(5):197-202. PubMed ID: 15508054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with persistence of red blood cell antibodies in woman after pregnancies complicated by fetal alloimmune haemolytic disease treated with intrauterine transfusions.
    Verduin EP; Brand A; van de Watering LM; Claas FH; Oepkes D; Lopriore E; Doxiadis II; Schonewille H
    Br J Haematol; 2015 Feb; 168(3):443-51. PubMed ID: 25244566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization.
    Van Kamp IL; Klumper FJ; Oepkes D; Meerman RH; Scherjon SA; Vandenbussche FP; Kanhai HH
    Am J Obstet Gynecol; 2005 Jan; 192(1):171-7. PubMed ID: 15672021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of pregnancies complicated by anti-E alloimmunization.
    Joy SD; Rossi KQ; Krugh D; O'Shaughnessy RW
    Obstet Gynecol; 2005 Jan; 105(1):24-8. PubMed ID: 15625137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interpretation of the direct antiglobulin test in neonates with haemolytic disease of the newborn.
    Tuladhar R; Patole SK; Whitehall JS
    Int J Clin Pract; 2000; 54(1):64. PubMed ID: 10750264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.